dyslipidemiaaspirinPREVENTequation≥ 126mg/dL1 dose; 2doses (2-6monthsapart) ifimmunocomp40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorHIVovariancancer≥ 100mg/dLGailmodel50y.o.multidoseinitial series,then 1 doseat 2-6monthstamoxifenHepatitisCTyrer-Cuzickmodel75y.o.insufficientevidenceforscreeningstatinq5ybreastcancerlungcancerdepressionq1yq1ymammogramq15yaromataseinhibitors52y.o.65y.o.FractureRiskAssessmentToolanxietycardiovasculardisease40y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorshormonetherapy≥6.5%community-dwelling,postmenopausalwomen60y.o.3%cervicalcancerdiabetes40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsoverweight/ obesity40-70 y.o.,ASCVD ≥10%, lowbleeding riskTimedup andgo test40-59 y.o.,ASCVD ≥10%, lowbleeding riskraloxifenepneumococcal2 doses,2-6monthsapartq3yherpeszoster≥ 140mg/dL≥ 200mg/dLtobaccousedementiaq2ywomenage 55-64 y.o.< 60y.o.HepatitisBq1-2ymammogrambased on lifeexpectancy /health status≤q2y≥5.7%hypertension≥20%colorectalcancer40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factordyslipidemiaaspirinPREVENTequation≥ 126mg/dL1 dose; 2doses (2-6monthsapart) ifimmunocomp40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorHIVovariancancer≥ 100mg/dLGailmodel50y.o.multidoseinitial series,then 1 doseat 2-6monthstamoxifenHepatitisCTyrer-Cuzickmodel75y.o.insufficientevidenceforscreeningstatinq5ybreastcancerlungcancerdepressionq1yq1ymammogramq15yaromataseinhibitors52y.o.65y.o.FractureRiskAssessmentToolanxietycardiovasculardisease40y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorshormonetherapy≥6.5%community-dwelling,postmenopausalwomen60y.o.3%cervicalcancerdiabetes40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsoverweight/ obesity40-70 y.o.,ASCVD ≥10%, lowbleeding riskTimedup andgo test40-59 y.o.,ASCVD ≥10%, lowbleeding riskraloxifenepneumococcal2 doses,2-6monthsapartq3yherpeszoster≥ 140mg/dL≥ 200mg/dLtobaccousedementiaq2ywomenage 55-64 y.o.< 60y.o.HepatitisBq1-2ymammogrambased on lifeexpectancy /health status≤q2y≥5.7%hypertension≥20%colorectalcancer40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factor

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
  1. dyslipidemia
  2. aspirin
  3. PREVENT equation
  4. ≥ 126 mg/dL
  5. 1 dose; 2 doses (2-6 months apart) if immunocomp
  6. 40-75 y.o.; LDL > 190 or ASCVD ≥ 10% + ≥ 1 risk factor
  7. HIV
  8. ovarian cancer
  9. ≥ 100 mg/dL
  10. Gail model
  11. 50 y.o.
  12. multidose initial series, then 1 dose at 2-6 months
  13. tamoxifen
  14. Hepatitis C
  15. Tyrer-Cuzick model
  16. 75 y.o.
  17. insufficient evidence for screening
  18. statin
  19. q5y
  20. breast cancer
  21. lung cancer
  22. depression
  23. q1y
  24. q1y mammogram
  25. q15y
  26. aromatase inhibitors
  27. 52 y.o.
  28. 65 y.o.
  29. Fracture Risk Assessment Tool
  30. anxiety
  31. cardiovascular disease
  32. 40 y.o.
  33. ≥ 40 y.o.; LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  34. hormone therapy
  35. ≥ 6.5%
  36. community-dwelling, postmenopausal women
  37. 60 y.o.
  38. 3%
  39. cervical cancer
  40. diabetes
  41. 40-75 y.o., LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  42. overweight / obesity
  43. 40-70 y.o., ASCVD ≥ 10%, low bleeding risk
  44. Timed up and go test
  45. 40-59 y.o., ASCVD ≥ 10%, low bleeding risk
  46. raloxifene
  47. pneumococcal
  48. 2 doses, 2-6 months apart
  49. q3y
  50. herpes zoster
  51. ≥ 140 mg/dL
  52. ≥ 200 mg/dL
  53. tobacco use
  54. dementia
  55. q2y
  56. women age 55-64 y.o.
  57. < 60 y.o.
  58. Hepatitis B
  59. q1-2y mammogram based on life expectancy / health status
  60. ≤ q2y
  61. ≥ 5.7%
  62. hypertension
  63. ≥20%
  64. colorectal cancer
  65. 40-75 y.o., ASCVD ≥ 7.5%, ≥ 1 risk factor